BRIEF published on 06/25/2024 at 16:05, 3 months 3 days ago Kyle Sawai Named Chief Marketing Officer of Liberty Tax Chief Marketing Officer Marketing Strategies Franchise Growth Liberty Tax Kyle Sawai
PRESS RELEASE published on 06/25/2024 at 16:00, 3 months 3 days ago Kyle Sawai Named Chief Marketing Officer of Liberty Tax Liberty Tax promotes Kyle Sawai to Chief Marketing Officer, focusing on US and Canadian consumers. Sawai's experience includes notable brands and digital strategies Marketing Digital Strategies Chief Marketing Officer Liberty Tax Kyle Sawai
BRIEF published on 06/03/2024 at 18:05, 3 months 25 days ago Liberty Tax Seeks New Franchise Partners Customer Service Franchising Opportunities Liberty Tax Franchise Disclosure Document Michael Miller
PRESS RELEASE published on 06/03/2024 at 18:00, 3 months 25 days ago Liberty Tax Seeks New Franchise Partners Liberty Tax announces the release of its updated Franchise Disclosure Document (FDD), inviting new franchise candidates. The FDD provides comprehensive information about the franchise opportunity and support for franchisees Franchise Opportunity Financial Goals Liberty Tax Franchise Disclosure Document Franchise Candidates
Published on 09/28/2024 at 02:06, 23 hours 25 minutes ago Global Education Communities Corp. Reports Second Tranche Closing of Non-Brokered Private Placement
Published on 09/28/2024 at 02:00, 23 hours 31 minutes ago Quantum Biopharma Provides Corporate Update
Published on 09/28/2024 at 02:00, 23 hours 31 minutes ago bettermoo(d)’s Moodrink(TM) Featured in Banners of Well-Known Canadian Retailers
Published on 09/28/2024 at 00:10, 1 day 1 hour ago LQWD Technologies Announces Non-Brokered Private Placement Update
Published on 09/28/2024 at 14:01, 11 hours 30 minutes ago Turkiye Garanti Bankasi A.S.: Explanation on Subordinated Debt Securities to Qualified Investors
Published on 09/27/2024 at 22:30, 1 day 3 hours ago DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
Published on 09/27/2024 at 21:56, 1 day 3 hours ago EQS-Adhoc: FDA grants approval for Stelara® Biosimilar FYB202/OtulfiTM (ustekinumab-aauz)
Published on 09/27/2024 at 18:50, 1 day 6 hours ago PETROFAC ANNOUNCES IN-PRINCIPLE AGREEMENT ON FINANCIAL RESTRUCTURE
Published on 09/27/2024 at 18:40, 1 day 6 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/27/2024 at 17:45, 1 day 7 hours ago NFL BIOSCIENCES: 2024 FIRST-HALF BUSINESS AND EARNINGS UPDATE
Published on 09/26/2024 at 18:00, 2 days 7 hours ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2024
Published on 09/26/2024 at 18:00, 2 days 7 hours ago GUILLEMOT CORPORATION: 2024 CONSOLIDATED INTERIM RESULTS
Published on 09/26/2024 at 17:47, 2 days 7 hours ago imerys-26-September-2024-information-share-capital-and-voting-rights-as-of-31-August-2024